Equity line shares sold
Company: Core Scientific
The claim, verbatim
As of October 26, 2022, Core Scientific had sold 13,354,892 shares under the B. Riley equity line of credit for net proceeds of approximately $20,700,000
Source (primary)
Core Scientific 424B3 filed 2022-10-27 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “As of October 26, 2022, the Company has sold 13,354,892 shares of common stock under B. Riley equity line of credit for net proceeds of approximately $20.7 million.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-27
Quote: “As of October 26, 2022, the Company has sold 13,354,892 shares of common stock under B. Riley equity line of credit for net proceeds of approximately $20.7 million.”